论文信息 - Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1. - 字舞流文

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1.

P. Ellis | S. Linn | J. Bonneterre | C. Barrios | F. Montemurro | S. Delaloge | A. Antón | R. Wuerstlein | N. Irahara | M. Donica | N. Lindegger | N. Quénel-Tueux